EUVIMEDEUVIMED entdecken
Crossref

Functional Foods and Bioactive Compounds in Managing Type 2 Diabetes Through Nutrigenomics

Abass A. Ohilebo, Mary U. Eigbobo, Shaibu Nasiru

Journal of PhytoPharmaceutical and Advanced Chemistry · 2026-08 · 1 (2) · 68-88

DOI: 10.66220/a2wsdj65 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of PhytoPharmaceutical and Advanced Chemistry, 2026-08. Verfasst von Abass A. Ohilebo und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) represents a major global health challenge driven by insulin resistance, β-cell dysfunction, chronic inflammation, oxidative stress, and gut dysbiosis. This review explores the emerging role of nutrigenomics in T2DM management, focusing on how functional foods and their bioactive compounds modulate gene expression, epigenetic mechanisms, and metabolic pathways to improve glycemic control. Key bioactive compounds (including resveratrol, curcumin, quercetin, genistein, berberine, EGCG, and omega-3 PUFAs) exert pleiotropic effects through activation of AMPK and SIRT1, inhibition of NF-κB, modulation of DNA methylation and histone acetylation, regulation of miRNAs, and enhancement of gut microbiota-derived short-chain fatty acids (SCFAs) such as butyrate. These actions collectively improve insulin sensitivity, protect β-cells, reduce inflammation, and restore metabolic homeostasis. Clinical evidence from randomized controlled trials and meta-analyses demonstrates significant reductions in fasting blood glucose, HbA1c, and HOMA-IR, with some compounds (such as curcumin) showing preventive efficacy in prediabetes. Despite challenges related to bioavailability and inter-individual genetic variation, advances in precision nutrition, multi-omics profiling, and formulation technologies position functional foods as a sustainable, mechanism-based complement to conventional pharmacotherapy. This nutrigenomic framework highlights the paradigm of “food as medicine” and underscores the need for personalized dietary interventions to combat the T2DM epidemic.

Zitieren

APA

Ohilebo, A. A., Eigbobo, M. U., & Nasiru, S. (2026). Functional Foods and Bioactive Compounds in Managing Type 2 Diabetes Through Nutrigenomics. Journal of PhytoPharmaceutical and Advanced Chemistry, 1(2), 68-88. https://doi.org/10.66220/a2wsdj65

Vancouver

Ohilebo AA, Eigbobo MU, Nasiru S. Functional Foods and Bioactive Compounds in Managing Type 2 Diabetes Through Nutrigenomics. Journal of PhytoPharmaceutical and Advanced Chemistry. 2026;1(2):68-88. doi:10.66220/a2wsdj65

BibTeX
@article{Ohilebo2026,
  author = {Ohilebo, Abass A. and Eigbobo, Mary U. and Nasiru, Shaibu},
  title = {Functional Foods and Bioactive Compounds in Managing Type 2 Diabetes Through Nutrigenomics},
  journal = {Journal of PhytoPharmaceutical and Advanced Chemistry},
  year = {2026},
  volume = {1},
  number = {2},
  pages = {68--88},
  doi = {10.66220/a2wsdj65}
}
Kostenlos starten →